These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease. Passamani ER Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348 [TBL] [Abstract][Full Text] [Related]
23. [Acetylsalicylic acid as free radical scavenger. An argument for increased dosages in acute and preventive therapy of vascular diseases]. Kuhn W; Müller T; Büttner T; Gerlach M Fortschr Med; 1995 Nov; 113(33):483-4. PubMed ID: 8575706 [No Abstract] [Full Text] [Related]
24. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy]. Krasnikova TL Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692 [No Abstract] [Full Text] [Related]
25. [Pharmacology of calcium antagonists]. Klaus W Fortschr Med; 1984 Jul; 102(27-28):728-31. PubMed ID: 6479816 [TBL] [Abstract][Full Text] [Related]
26. [Results of observations on the effectiveness of injections of sodium nitrite in the treatment of myopia]. Lopotko ZA Oftalmol Zh; 1966; 21(3):201-4. PubMed ID: 5992891 [No Abstract] [Full Text] [Related]
27. [A new combined therapy of intra-arterial drug injection and oral traditional Chinese medicines in treatment of thromboangiitis obliterans (author's transl)]. Chen ZQ Zhonghua Wai Ke Za Zhi; 1981 Sep; 19(9):558-60. PubMed ID: 7338116 [No Abstract] [Full Text] [Related]
28. [Cytochrome C in the combined therapy of patients with cerebral and coronary circulatory disorders]. Zinchenko VA; Sidorova ND Klin Med (Mosk); 1985 Sep; 63(9):49-51. PubMed ID: 2999506 [No Abstract] [Full Text] [Related]
29. Prostacyclin in the therapy of peripheral arterial disease. Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195 [No Abstract] [Full Text] [Related]
30. [Platelet adhesiveness and hemocoagulation in some thrombogenic vascular diseases]. Bertolotti T; Vergani G; Centonza D Folia Cardiol; 1967; 26(1):1-13. PubMed ID: 6072565 [No Abstract] [Full Text] [Related]
31. [Pharmacology of nitrites and adrenergic beta blockaders in coronary circulation]. Méndez R Arch Inst Cardiol Mex; 1980; 50(3):283-88. PubMed ID: 6107070 [No Abstract] [Full Text] [Related]
32. [RESULTS OF THE STUDY OF CARDIOVASCULAR DISEASES AMONG INDUSTRIAL WORKERS (DATA ON MORBIDITY WITH A TEMPORARY LOSS OF WORK CAPACITY)]. BURLOVA LIa; ELIZAROV VA Tr Leningr Sanitarnogig Med Inst; 1963; 72():5-10. PubMed ID: 14106502 [No Abstract] [Full Text] [Related]
33. [Anticholesteremic statins reduce myocardial infarction. Milestone studies give a straight answer--at least concerning the males]. Carlson LA Lakartidningen; 1999 Apr; 96(14):1725-8. PubMed ID: 10222689 [No Abstract] [Full Text] [Related]
34. Tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases. Guo SK; Chen KJ; Qian ZH; Weng WL; Qian MY Planta Med; 1983 Feb; 47(2):89. PubMed ID: 6844454 [No Abstract] [Full Text] [Related]
35. [On the clinical aspects of the cerebral form of obliterating thromboangiitis]. Il'ina NA; Kuuz RA Klin Med (Mosk); 1967 Jul; 45(7):109-13. PubMed ID: 5607726 [No Abstract] [Full Text] [Related]
36. The changing face of death: recent trends in Australian mortality. Ireland AW; Lawson JS Med J Aust; 1980 Jun; 1(12):587-90. PubMed ID: 6105614 [TBL] [Abstract][Full Text] [Related]
37. [Trends of cardiovascular disease in Italy]. Ferrario M; Vanuzzo D; Pilotto L; Vancheri F; Cesana G Ital Heart J; 2004 Nov; 5 Suppl 8():9S-18S; discussion 33S-34S, 116S-121S. PubMed ID: 15615355 [No Abstract] [Full Text] [Related]
38. [Effect of sodium nitrite on blood rheology, microcirculation and blood coagulability in patients with circulatory failure]. Murashko VV; Iusipova TA; Strutynskiĭ AV; Dzhanashiia PKh; Sheshina AM Ter Arkh; 1984; 56(4):108-11. PubMed ID: 6729712 [No Abstract] [Full Text] [Related]
39. Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study. Waters DD; LaRosa JC; Barter P; Fruchart JC; Gotto AM; Carter R; Breazna A; Kastelein JJ; Grundy SM J Am Coll Cardiol; 2006 Nov; 48(9):1793-9. PubMed ID: 17084252 [TBL] [Abstract][Full Text] [Related]
40. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy]. Blasi A; Licciardello M Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]